LUDWIG GROSS, M.D., F.A.C.P.
Recurrent, febrile parotitis in a 57-year-old woman was associated with repeated administration of oxyphenbutazone (Tandearil®). Only virus serology study may definitely distinguish this malady from epidemic parotitis. Possible mechanism and therapy of this condition are discussed.
Learn more about subscription options.
Register Now for a free account.
GROSS L. Oxyphenbutazone-Induced Parotitis. Ann Intern Med. 1969;70:1229–1230. doi: 10.7326/0003-4819-70-6-1229
Download citation file:
Published: Ann Intern Med. 1969;70(6):1229-1230.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only